These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 17353143)

  • 1. Application of spectrophotometric, densitometric, and HPLC techniques as stability indicating methods for determination of Zaleplon in pharmaceutical preparations.
    Metwally FH; Abdelkawy M; Abdelwahab NS
    Spectrochim Acta A Mol Biomol Spectrosc; 2007 Dec; 68(5):1220-30. PubMed ID: 17353143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectrophotometric and spectrodensitometric determination of Clopidogrel Bisulfate with kinetic study of its alkaline degradation.
    Zaazaa HE; Abbas SS; Abdelkawy M; Abdelrahman MM
    Talanta; 2009 May; 78(3):874-84. PubMed ID: 19269444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spectrophotometric and spectrodensitometric methods for the determination of rivastigmine hydrogen tartrate in presence of its degradation product.
    Salem MY; El-Kosasy AM; El-Bardicy MG; Abd El-Rahman MK
    Drug Test Anal; 2010 May; 2(5):225-33. PubMed ID: 20468010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability indicating spectrophotometric and spectrodensitometric methods for the determination of diatrizoate sodium in presence of its degradation product.
    Abd El-Rahman MK; Riad SM; Abdel Gawad SA; Fawaz EM; Shehata MA
    Spectrochim Acta A Mol Biomol Spectrosc; 2015 Feb; 136 Pt B():1167-74. PubMed ID: 25456658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spectrophotometric and spectrodensitometric determination of paracetamol and drotaverine HCl in combination.
    Abdellatef HE; Ayad MM; Soliman SM; Youssef NF
    Spectrochim Acta A Mol Biomol Spectrosc; 2007 Apr; 66(4-5):1147-51. PubMed ID: 17045518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability-indicating spectrophotometric and spectrodensitometric methods for the determination of diacerein in the presence of its degradation product.
    Nebsen M; Abd El-Rahman MK; Salem MY; El-Kosasy AM; El-Bardicy MG
    Drug Test Anal; 2011 Apr; 3(4):221-7. PubMed ID: 21500366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of nifuroxazide and drotaverine hydrochloride in pharmaceutical preparations by three independent analytical methods.
    Metwally FH; Abdelkawy M; Naguib IA
    J AOAC Int; 2006; 89(1):78-87. PubMed ID: 16512232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability-indicating methods for determination of tiapride in pure form, pharmaceutical preparation, and human plasma.
    Metwally FH; Abdelkawy M; Abdelwahab NS
    J AOAC Int; 2007; 90(6):1554-65. PubMed ID: 18193732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study on various spectrometries with thin layer chromatography for simultaneous analysis of drotaverine and nifuroxazide in capsules.
    Ayad MM; Youssef NF; Abdellatif HE; Soliman SM
    Chem Pharm Bull (Tokyo); 2006 Jun; 54(6):807-13. PubMed ID: 16755048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability indicating reversed-phase high-performance liquid chromatographic and thin layer densitometric methods for the determination of ziprasidone in bulk powder and in pharmaceutical formulations.
    El-Sherif ZA; El-Zeany B; El-Houssini OM; Rashed MS; Aboul-Enein HY
    Biomed Chromatogr; 2004 Apr; 18(3):143-9. PubMed ID: 15103698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability-indicating methods for the determination of piretanide in presence of the alkaline induced degradates.
    Youssef NF
    J Pharm Biomed Anal; 2005 Oct; 39(5):871-6. PubMed ID: 16223647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of a rapid stability indicating HPLC-method using monolithic stationary phase and two spectrophotometric methods for determination of antihistaminic acrivastine in capsules.
    Gouda AA; Hashem H; Jira T
    Spectrochim Acta A Mol Biomol Spectrosc; 2014 Sep; 130():480-7. PubMed ID: 24813276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of cisapride in pharmaceutical preparations using derivative spectrophotometry.
    Hassan EM; Hagga ME; Al Johar HI
    J Pharm Biomed Anal; 2001 Feb; 24(4):659-65. PubMed ID: 11272323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a stability-indicating high performance liquid chromatographic (HPLC) assay for biperiden in bulk form and pharmaceutical dosage forms.
    Mohammadi A; Mehramizi A; Moghaddam FA; Jabarian LE; Pourfarzib M; Kashani HN
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jul; 854(1-2):152-7. PubMed ID: 17466605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability-indicating methods for determination of vincamine in presence of its degradation product.
    Shehata MA; El Sayed MA; El Tarras MF; El Bardicy MG
    J Pharm Biomed Anal; 2005 Jun; 38(1):72-8. PubMed ID: 15907622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validated spectrophotometric and chromatographic methods for simultaneous determination of ketorolac tromethamine and phenylephrine hydrochloride.
    Belal TS; El-Kafrawy DS; Mahrous MS; Abdel-Khalek MM; Abo-Gharam AH
    Ann Pharm Fr; 2016 Jul; 74(4):267-82. PubMed ID: 26895689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of spectrophotometric, TLC and HPLC methods for the determination of lamotrigine in presence of its impurity.
    Youssef NF; Taha EA
    Chem Pharm Bull (Tokyo); 2007 Apr; 55(4):541-5. PubMed ID: 17409544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability indicating methods for the determination of diloxanide furoate.
    Hasan NY; Elkawy MA; Elzeany BE; Wagieh NE
    J Pharm Biomed Anal; 2002 Apr; 28(2):187-97. PubMed ID: 11929661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of three stability-indicating methods for determination of bisacodyl in pure form and pharmaceutical preparations.
    Metwally FH; Abdelkawy M; Naguib IA
    J AOAC Int; 2007; 90(1):113-27. PubMed ID: 17373442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative determination of oxybutynin hydrochloride by spectrophotometry, chemometry and HPTLC in presence of its degradation product and additives in different pharmaceutical dosage forms.
    Wagieh NE; Hegazy MA; Abdelkawy M; Abdelaleem EA
    Talanta; 2010 Mar; 80(5):2007-15. PubMed ID: 20152446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.